{"id":516222,"date":"2021-07-22T07:04:41","date_gmt":"2021-07-22T11:04:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/"},"modified":"2021-07-22T07:04:41","modified_gmt":"2021-07-22T11:04:41","slug":"oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/","title":{"rendered":"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <i>Conference call and webcast to take place on <span class=\"xn-chron\">Friday, August 6, 2021<\/span>, at <span class=\"xn-chron\">8:00 a.m. ET<\/span><\/i>\n      <\/p>\n<p>\n        <span class=\"xn-location\">SAN DIEGO<\/span> and <span class=\"xn-location\">CALGARY, AB<\/span>, <b><span class=\"xn-chron\">July 22, 2021<\/span><\/b> \/PRNewswire\/<b>\u00a0<\/b>&#8212; Oncolytics Biotech<sup>\u00ae<\/sup>\u00a0Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on <span class=\"xn-chron\">Friday, August 6, 2021<\/span>, at <span class=\"xn-chron\">8:00 a.m. ET<\/span> to discuss a corporate update and financial results for the second quarter 2021.<\/p>\n<div id=\"prni_dvprnejpg7b32left\" dir=\"ltr\">\n        <img decoding=\"async\" id=\"prnejpg7b32left\" title=\"Oncolytics_Logo\" border=\"0\" alt=\"Oncolytics_Logo\" align=\"middle\" src=\"https:\/\/mma.prnewswire.com\/media\/1064079\/Oncolytics_Logo.jpg\" \/>\n      <\/div>\n<p>\n        <b><br \/>\n          <u>Conference Call &amp; Webcast<\/u><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <b>Date:<\/b>\u00a0Friday, August 6, 2021<br \/><b>Time:<\/b>\u00a08:00 a.m. Eastern Daylight Time<br \/><b>Dial In \u2013 North American Toll-Free:<\/b>\u00a0(888) 664-6383<br \/><b>Dial In \u2013 International:<\/b>\u00a0(416) 764-8650<br \/><b>Conference ID <\/b>(if needed)<b>:<\/b> 5114-8191<br \/><b>Webcast:<\/b>\u00a0please <a target=\"_blank\" href=\"https:\/\/produceredition.webcasts.com\/starthere.jsp?ei=1480405&amp;tp_key=3c3ee7b8e9\" rel=\"nofollow noopener\">click here<\/a><\/p>\n<p>A webcast of the call will also be available on the Investor Relations page of Oncolytics&#8217; website, available by clicking\u00a0<a target=\"_blank\" href=\"https:\/\/ir.oncolyticsbiotech.com\/events-presentations\" rel=\"nofollow noopener\">here<\/a>, and will be archived for three months. A dial in replay will be available for one week and can be accessed by dialing (888) 390-0541 (<span class=\"xn-location\">North America<\/span>) or (416) 764-8677 (International) and using reference code: 148-191#.<\/p>\n<p>\n        <b>About Oncolytics Biotech Inc.<\/b>\n      <\/p>\n<p>Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype &#8212; turning &#8220;cold&#8221; tumors &#8220;hot&#8221; &#8212; through innate and adaptive immune responses to treat a variety of cancers.<\/p>\n<p>Pelareorep has demonstrated synergies with immune checkpoint inhibitors and may also be synergistic with other approved oncology treatments. Oncolytics is currently conducting and planning clinical trials evaluating pelareorep in combination with checkpoint inhibitors and targeted therapies in solid and hematological malignancies as it advances towards a registration study in metastatic breast cancer. For further information, please visit: <a target=\"_blank\" href=\"http:\/\/www.oncolyticsbiotech.com\/\" rel=\"nofollow noopener\">www.oncolyticsbiotech.com<\/a>.<\/p>\n<p>\n        <i>This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended and forward-looking information under applicable Canadian securities laws (such forward-looking statements and forward-looking information are collectively referred to herein as &#8220;forward-looking statements&#8221;). Forward-looking statements contained in this press release include statements regarding Oncolytics&#8217; belief as to the potential and benefits of pelareorep as a cancer therapeutic; Oncolytics&#8217; expectations as to the purpose, design, outcomes and benefits of its current or pending clinical trials involving pelareorep; and other statements related to anticipated developments in Oncolytics&#8217; business and technologies.\u00a0 In any forward-looking statement in which Oncolytics expresses an expectation or belief as to future results, such expectations or beliefs are expressed in good faith and are believed to have a reasonable basis, but there can be no assurance that the statement or expectation or belief will be achieved. Such forward-looking statements involve known and unknown risks and uncertainties, which could cause Oncolytics&#8217; actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of pelareorep as a cancer treatment, the success and timely completion of clinical studies and trials, Oncolytics&#8217; ability to successfully commercialize pelareorep, uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. In particular, we may be impacted by business interruptions resulting from COVID-19 coronavirus, including operating, manufacturing supply chain, clinical trial and project development delays and disruptions, labour shortages, travel and shipping disruption, and shutdowns (including as a result of government regulation and prevention measures). It is unknown whether and how Oncolytics may be affected if the COVID-19 pandemic persists for an extended period of time. We may incur expenses or delays relating to such events outside of our control, which could have a material adverse impact on our business, operating results and financial condition.\u00a0 Investors should consult Oncolytics&#8217; quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake any obligation to update these forward-looking statements, except as required by applicable laws.<\/i>\n      <\/p>\n<div class=\"prntal\">\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prntblns\">\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Company Contact <\/b><br \/>\n                <\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Jon Patton<\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Director of IR &amp; Communication<\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">+1-858-886-7813<\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:jpatton@oncolytics.ca\" class=\"prnews_a\" rel=\"nofollow noopener\">jpatton@oncolytics.ca<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Investor Relations for Oncolytics<\/b><br \/>\n                <\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">Timothy McCarthy<\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">LifeSci Advisors<\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\">+1-917-679-9282<\/span>\n              <\/p>\n<p class=\"prnews_p\">\n                <span class=\"prnews_span\"><br \/>\n                  <a target=\"_blank\" href=\"mailto:tim@lifesciadvisors.com\" class=\"prnews_a\" rel=\"nofollow noopener\">tim@lifesciadvisors.com<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO51583&amp;sd=2021-07-22\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights-301339270.html\">https:\/\/www.prnewswire.com\/news-releases\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights-301339270.html<\/a><\/p>\n<p>SOURCE  Oncolytics Biotech\u00ae Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=IO51583&amp;Transmission_Id=202107220700PR_NEWS_USPR_____IO51583&amp;DateId=20210722\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Conference call and webcast to take place on Friday, August 6, 2021, at 8:00 a.m. ET SAN DIEGO and CALGARY, AB, July 22, 2021 \/PRNewswire\/\u00a0&#8212; Oncolytics Biotech\u00ae\u00a0Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Friday, August 6, 2021, at 8:00 a.m. ET to discuss a corporate update and financial results for the second quarter 2021. Conference Call &amp; Webcast Date:\u00a0Friday, August 6, 2021Time:\u00a08:00 a.m. Eastern Daylight TimeDial In \u2013 North American Toll-Free:\u00a0(888) 664-6383Dial In \u2013 International:\u00a0(416) 764-8650Conference ID (if needed): 5114-8191Webcast:\u00a0please click here A webcast of the call will also be available on the Investor Relations page of Oncolytics&#8217; website, available by clicking\u00a0here, and will be archived for three &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-516222","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Conference call and webcast to take place on Friday, August 6, 2021, at 8:00 a.m. ET SAN DIEGO and CALGARY, AB, July 22, 2021 \/PRNewswire\/\u00a0&#8212; Oncolytics Biotech\u00ae\u00a0Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Friday, August 6, 2021, at 8:00 a.m. ET to discuss a corporate update and financial results for the second quarter 2021. Conference Call &amp; Webcast Date:\u00a0Friday, August 6, 2021Time:\u00a08:00 a.m. Eastern Daylight TimeDial In \u2013 North American Toll-Free:\u00a0(888) 664-6383Dial In \u2013 International:\u00a0(416) 764-8650Conference ID (if needed): 5114-8191Webcast:\u00a0please click here A webcast of the call will also be available on the Investor Relations page of Oncolytics&#8217; website, available by clicking\u00a0here, and will be archived for three &hellip; Continue reading &quot;Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-22T11:04:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1064079\/Oncolytics_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights\",\"datePublished\":\"2021-07-22T11:04:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/\"},\"wordCount\":698,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064079\\\/Oncolytics_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/\",\"name\":\"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064079\\\/Oncolytics_Logo.jpg\",\"datePublished\":\"2021-07-22T11:04:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064079\\\/Oncolytics_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064079\\\/Oncolytics_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/","og_locale":"en_US","og_type":"article","og_title":"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights - Market Newsdesk","og_description":"PR Newswire Conference call and webcast to take place on Friday, August 6, 2021, at 8:00 a.m. ET SAN DIEGO and CALGARY, AB, July 22, 2021 \/PRNewswire\/\u00a0&#8212; Oncolytics Biotech\u00ae\u00a0Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Friday, August 6, 2021, at 8:00 a.m. ET to discuss a corporate update and financial results for the second quarter 2021. Conference Call &amp; Webcast Date:\u00a0Friday, August 6, 2021Time:\u00a08:00 a.m. Eastern Daylight TimeDial In \u2013 North American Toll-Free:\u00a0(888) 664-6383Dial In \u2013 International:\u00a0(416) 764-8650Conference ID (if needed): 5114-8191Webcast:\u00a0please click here A webcast of the call will also be available on the Investor Relations page of Oncolytics&#8217; website, available by clicking\u00a0here, and will be archived for three &hellip; Continue reading \"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-22T11:04:41+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1064079\/Oncolytics_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights","datePublished":"2021-07-22T11:04:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/"},"wordCount":698,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064079\/Oncolytics_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/","name":"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064079\/Oncolytics_Logo.jpg","datePublished":"2021-07-22T11:04:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1064079\/Oncolytics_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1064079\/Oncolytics_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oncolytics-biotech-to-host-conference-call-to-discuss-second-quarter-financial-results-and-operational-highlights\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oncolytics Biotech\u00ae to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=516222"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/516222\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=516222"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=516222"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=516222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}